CD1d-Restricted Type II NKT Cells Reactive With Endogenous Hydrophobic Peptides
Overview
Affiliations
NKT cells belong to a distinct subset of T cells that recognize hydrophobic antigens presented by major histocompatibility complex class I-like molecules, such as CD1d. Because NKT cells stimulated by antigens can activate or suppress other immunocompetent cells through an immediate production of a large amount of cytokines, they are regarded as immunological modulators. CD1d-restricted NKT cells are classified into two subsets, namely, type I and type II. CD1d-restricted type I NKT cells express invariant T cell receptors (TCRs) and react with lipid antigens, including the marine sponge-derived glycolipid α-galactosylceramide. On the contrary, CD1d-restricted type II NKT cells recognize a wide variety of antigens, including glycolipids, phospholipids, and hydrophobic peptides, by their diverse TCRs. In this review, we focus particularly on CD1d-restricted type II NKT cells that recognize endogenous hydrophobic peptides presented by CD1d. Previous studies have demonstrated that CD1d-restricted type I NKT cells usually act as pro-inflammatory cells but sometimes behave as anti-inflammatory cells. It has been also demonstrated that CD1d-restricted type II NKT cells play opposite roles to CD1d-restricted type I NKT cells; thus, they function as anti-inflammatory or pro-inflammatory cells depending on the situation. In line with this, CD1d-restricted type II NKT cells that recognize type II collagen peptide have been demonstrated to act as anti-inflammatory cells in diverse inflammation-induction models in mice, whereas pro-inflammatory CD1d-restricted type II NKT cells reactive with sterol carrier protein 2 peptide have been demonstrated to be involved in the development of small vessel vasculitis in rats.
CAR-NKT Cells in Asthma: Use of NKT as a Promising Cell for CAR Therapy.
Mohammad Taheri M, Javan F, Poudineh M, Athari S Clin Rev Allergy Immunol. 2024; 66(3):328-362.
PMID: 38995478 DOI: 10.1007/s12016-024-08998-0.
Mohammed A, Ball R, Jolly A, Nagarkatti P, Nagarkatti M, Kubinak J Front Immunol. 2024; 15:1278197.
PMID: 38803492 PMC: 11128607. DOI: 10.3389/fimmu.2024.1278197.
Unconventional T cells in brain homeostasis, injury and neurodegeneration.
Lv M, Zhang Z, Cui Y Front Immunol. 2023; 14:1273459.
PMID: 37854609 PMC: 10579804. DOI: 10.3389/fimmu.2023.1273459.
Sterol carrier protein 2: A promising target in the pathogenesis of atherosclerosis.
Xu C, Li H, Tang C Genes Dis. 2023; 10(2):457-467.
PMID: 37223526 PMC: 10201558. DOI: 10.1016/j.gendis.2021.12.007.
SFRP4IGFBP5 NKT cells induced neural-like cell differentiation to contribute to adenomyosis pain.
Chen Y, Zhu J, Chen L, Shen Y, Zhang J, Wang Q Front Immunol. 2022; 13:945504.
PMID: 36532077 PMC: 9750790. DOI: 10.3389/fimmu.2022.945504.